Cantabio Pharmaceuticals Inc
OTC:CTBO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
US |
|
HELMA Eigenheimbau AG
XETRA:H5E
|
DE |
|
N
|
Norconsult ASA
OSE:NORCO
|
NO |
|
Dorel Industries Inc
F:DO4C
|
CA |
|
F
|
Foxsemicon Integrated Technology Inc
TWSE:3413
|
TW |
Bankruptcy Probability
Cantabio Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cantabio Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
19.5k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
12.4T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
3.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
3.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
T
|
TransThera Sciences (Nanjing) Inc
HKEX:2617
|
27.8B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alumis Inc
NASDAQ:ALMS
|
2.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
V
|
Veradermics Inc
NYSE:MANE
|
2.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
2.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
N
|
Nanjing Leads Biolabs Co Ltd
HKEX:9887
|
16.8B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cantabio Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cantabio Pharmaceuticals Inc has total debt of 1.4m USD. This includes both short-term (1.4m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
